Medpace Holdings, Inc.: AQR CAPITAL MANAGEMENT LLC discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
AQR Capital Management LLC disclosed a stake exceeding 5% in Medpace Holdings, Inc. via a Schedule 13G filing with the SEC (accession 0001167557-26-000279). The passive-investment disclosure signals the quantitative asset manager has built a meaningful position in the clinical research organization. The exact share count and percentage were not specified in the filing headline. Investors will watch for further 13G amendments or 13D filings that could indicate a shift from passive to activist intent.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Medpace Holdings, Inc., AQR Capital Management LLC